Kaposiform Hemangioendothelioma (KHE)
2 clinical trials · Condition
◉ Watch Kaposiform Hemangioendothelioma (KHE)
| Record | Firm | Date |
|---|---|---|
| A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors (NCT02110069) | Boston Children's Hospital | 2017-06-14 |
Track Kaposiform Hemangioendothelioma (KHE) automatically
Every clearance here is in the API, with alerts when new ones post.